Search Results

There are 13608 results for: content related to: Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study

  1. The Convergence of Medicine and Neurotoxins: A Focus on Botulinum Toxin Type A and Its Application in Aesthetic Medicine—A Global, Evidence-Based Botulinum Toxin Consensus Education Initiative

    Dermatologic Surgery

    Volume 39, Issue 3pt2, March 2013, Pages: 493–509, Alastair Carruthers, Michael A. C. Kane, Timothy C. Flynn, Peter Huang, Sang D. Kim, Nowell Solish and Gina Kaeuper

    Version of Record online : 4 MAR 2013, DOI: 10.1111/dsu.12147

  2. A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches

    Cephalalgia

    Volume 27, Issue 6, June 2007, Pages: 492–503, M Relja, AC Poole, J Schoenen, J Pascual, X Lei, C Thompson and for the European BoNTA Headache Study Group

    Version of Record online : 11 APR 2007, DOI: 10.1111/j.1468-2982.2007.01315.x

  3. Botulinum Toxin Type A and Divalproex Sodium for Prophylactic Treatment of Episodic or Chronic Migraine

    Headache: The Journal of Head and Face Pain

    Volume 48, Issue 2, February 2008, Pages: 210–220, Andrew M. Blumenfeld, Jack D. Schim and Thomas J. Chippendale

    Version of Record online : 28 NOV 2007, DOI: 10.1111/j.1526-4610.2007.00949.x

  4. Predictors of Response to Botulinum Toxin Type A (BoNTA) in Chronic Daily Headache

    Headache: The Journal of Head and Face Pain

    Volume 48, Issue 2, February 2008, Pages: 194–200, Ninan T. Mathew, Jayasree Kailasam and Lori Meadors

    Version of Record online : 14 SEP 2007, DOI: 10.1111/j.1526-4610.2007.00914.x

  5. You have free access to this content
    Botulinum Toxin Type A Prophylactic Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Exploratory Study

    Headache: The Journal of Head and Face Pain

    Volume 47, Issue 4, April 2007, Pages: 486–499, Sheena K. Aurora, Marek Gawel, Jan L. Brandes, Suriani Pokta, Amanda M. VanDenburgh and for the BOTOX North American Episodic Migraine Study Group

    Version of Record online : 29 NOV 2006, DOI: 10.1111/j.1526-4610.2006.00624.x

  6. Saturday Poster Presentations - 2

    Headache: The Journal of Head and Face Pain

    Volume 45, Issue 6, June 2005, Pages: 823–840,

    Version of Record online : 15 JUN 2005, DOI: 10.1111/j.1526-4610.2005.00823.x

  7. You have full text access to this OnlineOpen article
    Botulinum neurotoxin type A modulates vesicular release of glutamate from satellite glial cells

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 8, August 2015, Pages: 1900–1909, Larissa Bittencourt da Silva, Jeppe Nørgaard Poulsen, Lars Arendt-Nielsen and Parisa Gazerani

    Version of Record online : 5 MAR 2015, DOI: 10.1111/jcmm.12562

  8. Botulinum Toxin Type A Treatment of Multiple Upper Facial Sites: Patient-Reported Outcomes

    Dermatologic Surgery

    Volume 33, Issue s1, January 2007, Pages: S10–S17, JEAN CARRUTHERS and ALASTAIR CARRUTHERS

    Version of Record online : 2 JAN 2007, DOI: 10.1111/j.1524-4725.2006.32326.x

  9. Botulinum Toxin Type A as Migraine Preventive Treatment in Patients Previously Failing Oral Prophylactic Treatment Due To Compliance Issues

    Headache: The Journal of Head and Face Pain

    Volume 48, Issue 6, June 2008, Pages: 900–913, Roger Cady and Curtis Schreiber

    Version of Record online : 28 NOV 2007, DOI: 10.1111/j.1526-4610.2007.00953.x

  10. You have free access to this content
    Discontinuation rates and inter-injection interval for repeated intravesical botulinum toxin type A injections for detrusor overactivity

    International Journal of Urology

    Volume 21, Issue 2, February 2014, Pages: 175–178, Rajan Veeratterapillay, Chris Harding, Luke Teo, Nikhil Vasdev, Ahmed Abroaf, Trevor J Dorkin, Robert S Pickard, Tahseen Hasan and Andrew C Thorpe

    Version of Record online : 2 JUL 2013, DOI: 10.1111/iju.12205

  11. Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay

    Movement Disorders

    Volume 23, Issue 10, 30 July 2008, Pages: 1353–1360, Mitchell F. Brin, Cynthia L. Comella, Joseph Jankovic, Francis Lai and Markus Naumann

    Version of Record online : 10 JUN 2008, DOI: 10.1002/mds.22157

  12. Muscle histopathology in children with spastic cerebral palsy receiving botulinum toxin type A

    Muscle & Nerve

    Volume 53, Issue 3, March 2016, Pages: 407–414, Jane Valentine, Katherine Stannage, Vicki Fabian, Kevin Ellis, Siobhan Reid, Christian Pitcher and Catherine Elliott

    Version of Record online : 5 JAN 2016, DOI: 10.1002/mus.24763

  13. You have free access to this content
    Effects of selective paralysis of the supraspinatus muscle using botulinum neurotoxin a in rotator cuff healing in rats

    Journal of Orthopaedic Research

    Volume 31, Issue 5, May 2013, Pages: 716–723, Andreas Ficklscherer, Tessa-Katharina Hartl, Markus Scharf, Birte Sievers, Christian Schröder, Stefan Milz, Thomas Niethammer, Matthias F. Pietschmann and Peter E. Müller

    Version of Record online : 13 DEC 2012, DOI: 10.1002/jor.22260

  14. Different formulations of botulinum toxin type A have different migration characteristics: a double-blind, randomized study

    Journal of Cosmetic Dermatology

    Volume 7, Issue 1, March 2008, Pages: 50–54, Sandeep H Cliff, Harryono Judodihardjo and Elizabeth Eltringham

    Version of Record online : 31 JAN 2008, DOI: 10.1111/j.1473-2165.2008.00361.x

  15. A Double-Blind, Randomized, Placebo-Controlled Comparison of Botulinum Toxin Type A Injection Sites and Doses in the Prevention of Episodic Migraine

    Pain Medicine

    Volume 8, Issue 6, September 2007, Pages: 478–485, Joel R. Saper, Ninan T. Mathew, Elizabeth W. Loder, Ronald DeGryse, Amanda M. VanDenburgh and for the BoNTA-009 Study Group

    Version of Record online : 1 FEB 2007, DOI: 10.1111/j.1526-4637.2006.00168.x

  16. A Double-Blind, Randomized, Placebo-Controlled Health-Outcomes Survey of the Effect of Botulinum Toxin Type A Injections on Quality of Life and Self-Esteem

    Dermatologic Surgery

    Volume 36, Issue s4, December 2010, Pages: 2088–2097, STEVEN H. DAYAN, JOHN P. ARKINS, AMIT B. PATEL and THOMAS J. GAL

    Version of Record online : 11 NOV 2010, DOI: 10.1111/j.1524-4725.2010.01795.x

  17. Pilot Study Comparing the Diffusion of Two Formulations of Botulinum Toxin Type A in Patients with Forehead Hyperhidrosis

    Dermatologic Surgery

    Volume 33, Issue s1, January 2007, Pages: S37–S43, ADA R. TRINDADE DE ALMEIDA, ELISA MARQUES, JANETE DE ALMEIDA, THAIS CUNHA and ROSANA BORASO

    Version of Record online : 2 JAN 2007, DOI: 10.1111/j.1524-4725.2006.32330.x

  18. Comparing two botulinum toxin type A formulations using manufacturers’ product summaries

    Journal of Clinical Pharmacy and Therapeutics

    Volume 32, Issue 4, August 2007, Pages: 387–402, R. Wenzel, D. Jones and J. A. Borrego

    Version of Record online : 17 JUL 2007, DOI: 10.1111/j.1365-2710.2007.00835.x

  19. The Convergence of Medicine and Neurotoxins: A Focus on Botulinum Toxin Type A and Its Application in Aesthetic Medicine—A Global, Evidence-Based Botulinum Toxin Consensus Education Initiative

    Dermatologic Surgery

    Volume 39, Issue 3pt2, March 2013, Pages: 510–525, Jean Carruthers, Nathalie Fournier, Martina Kerscher, Javier Ruiz-Avila, Ada R. Trindade de Almeida and Gina Kaeuper

    Version of Record online : 4 MAR 2013, DOI: 10.1111/dsu.12148

  20. The Prophylactic Treatment of Chronic Daily Headache

    Headache: The Journal of Head and Face Pain

    Volume 46, Issue 10, November/December 2006, Pages: 1552–1564, Ninan T. Mathew

    Version of Record online : 9 NOV 2006, DOI: 10.1111/j.1526-4610.2006.00621.x